Molecular insights into early malignant transition of hepatocellular carcinoma
Authors:
Preprint
Abstract
The molecular continuum of premalignant-to-malignant transition remains elusive in carcinogenesis, primarily due to the difficulty in sampling transitional lesions. Here, we present comprehensive genomic and immunological profiling of 21 very early hepatocellular carcinomas (veHCCs) arising within 17 cancer-prone DNs. Surprisingly, 82% of cancer-prone DNs harbored TERT alterations, suggesting a predisposing rather than causative role in malignancy transition. A substantial increase in CNA burden, rather than SNV, was noted, indicating a role of chromosome instability in malignancy transition. Additionally, veHCC-originating DNs showed immune inactivity, not falling into the prevailing paradigm that HCCs develop in a context of chronic inflammation. 43% of veHCCs showed an inflamed phenotype with relatively mild CNA burden but already exhibited immune evasion features. Two major evolutionary scenarios were thus proposed: 1) CNA-dominant progression and 2) early immune evasion of those with mild CNA burden. Collectively, our findings illustrate previously unexplored molecular paradigms in HCC initiation, highlighting the therapeutic potential of immunotherapy for early intervention.Keywords
All Related Versions
- Published version: Cancer Cell, 44 (5), 1012.
This publication has 73 references indexed in Scilit:
- A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cellsCell, 2021
- Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qCell Reports, 2020
- TERT promoter mutations and telomeres during tumorigenesisCurrent Opinion in Genetics & Development, 2020
- Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver DiseaseCell, 2019
- Comprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaCell, 2017
- ONGene: A literature-based database for human oncogenesJournal of Genetics and Genomics, 2017
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisHepatology, 2014
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009